
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. is a medical device development company that has completed design, development, and testing of its Orbital Atherectomy Device intended for removal of atherosclerotic blockages in coronary and peripheral arteries.
| Company | Cardiovascular Systems, Inc. |
|---|---|
| URL | http://www.cardiovascularsystemsinc.com/ |
Data Discussed at TCT on September 22
Cardiovascular Systems and Replidyne Complete Merger
Cardiovascular Systems, Inc. approved for trading on NASDAQ Global Market®
Cardiovascular Systems Signs Merger Agreement
Merger to create NASDAQ-listed medical device company focused on developing and commercializing interventional treatment systems for vascular disease;
St. Paul, MN - Cardiovascular Systems, Inc. (CSI) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock.
CSI Announces Closing Of $25 Million Financing Round
CSI Announces Closing Of $25 Million Financing Round
MVC Corporation Changes Name to Mitsui & Co. Global Investment, Ltd.
MCVP Changes Name and Relocates Office
Notice on Relocation of MVC Head Office
Mitsui Ventures invested USD 5 M in S*BIO
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
